Influenza A Virus H1N1 Beijing 262/95 (Recombinant)

Recombinant Hemagglutinin H1N1 New Caledonia 20/99

Source: Insect cells

Description: Recombinant Hemagglutinin is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 57,500 dalton. Hemagglutinin is purified by proprietary chromatographic techniques.

Physical Appearance: Sterile clear liquid formulation.

Formulation: (0.113mg/ml) solution containing 30mM Sodium phosphate, pH 7 and 500mM NaCl.

Stability: rHA although stable at 150C for 2 weeks, should be stored at 40C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please avoid freeze-thaw cycles.

Purity: Greater than 90.0% as determined by: (a) Analysis by RP-HPLC. (b) Anion-exchange FPLC. (c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.

Dimers and aggregates: Less than 1% as determined by silver-stained SDS-PAGE gel analysis.

Endotoxin: Less than 0.1 ng/ g (IEU/ g) of Hemagglutinin.

Usage: BioWORLD\\\'s products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.